Korea United Pharm Inc
KRX:033270

Watchlist Manager
Korea United Pharm Inc Logo
Korea United Pharm Inc
KRX:033270
Watchlist
Price: 19 600 KRW -0.15% Market Closed
Market Cap: 288.3B KRW

Intrinsic Value

The intrinsic value of one Korea United Pharm Inc stock under the Base Case scenario is hidden KRW. Compared to the current market price of 19 600 KRW, Korea United Pharm Inc is hidden .

The Intrinsic Value is calculated as the average of DCF and Relative values:

Korea United Pharm Inc Intrinsic Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Valuation History
Korea United Pharm Inc

Intrinsic Value History
Dive into the past to invest in the future

Korea United Pharm Inc looks undervalued. But is it really? Some stocks live permanently below intrinsic value; one glance at Historical Valuation reveals if Korea United Pharm Inc is one of them.

Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Show Historical Valuation
What is Valuation History?
Ask AI Assistant
What other research platforms think about Korea United Pharm Inc?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is Korea United Pharm Inc valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Korea United Pharm Inc.

Explain Valuation
Compare Korea United Pharm Inc to

Fundamental Analysis

Company Overview
Loading...
Economic Moat
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about Korea United Pharm Inc?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Korea United Pharm Inc

Current Assets 250.7B
Cash & Short-Term Investments 130.5B
Receivables 54.7B
Other Current Assets 65.4B
Non-Current Assets 228B
Long-Term Investments 56.3B
PP&E 160.1B
Intangibles 9.2B
Other Non-Current Assets 2.4B
Current Liabilities 46.1B
Accounts Payable 9.1B
Accrued Liabilities 17.9B
Other Current Liabilities 19.1B
Non-Current Liabilities 18.9B
Long-Term Debt 13.1B
Other Non-Current Liabilities 5.8B
Efficiency

Free Cash Flow Analysis
Korea United Pharm Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Korea United Pharm Inc

Revenue
286.3B KRW
Cost of Revenue
-126.9B KRW
Gross Profit
159.4B KRW
Operating Expenses
-108B KRW
Operating Income
51.4B KRW
Other Expenses
-17.9B KRW
Net Income
33.5B KRW
Fundamental Scores

Profitability Score
Profitability Due Diligence

Korea United Pharm Inc's profitability score is hidden . The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin
Strong 3Y Average Gross Margin
Positive 3Y Average ROIC
Healthy Operating Margin
hidden
Profitability
Score

Korea United Pharm Inc's profitability score is hidden . The higher the profitability score, the more profitable the company is.

Solvency Score
Solvency Due Diligence

Korea United Pharm Inc's solvency score is hidden . The higher the solvency score, the more solvent the company is.

High Interest Coverage
High Altman Z-Score
Short-Term Solvency
Long-Term Solvency
hidden
Solvency
Score

Korea United Pharm Inc's solvency score is hidden . The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

Price Targets Summary
Korea United Pharm Inc

Wall Street analysts forecast Korea United Pharm Inc stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Korea United Pharm Inc is 29 580 KRW with a low forecast of 28 280 KRW and a high forecast of 31 500 KRW.

Lowest
Price Target
28 280 KRW
44% Upside
Average
Price Target
29 580 KRW
51% Upside
Highest
Price Target
31 500 KRW
61% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for Korea United Pharm Inc is hidden .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
HIDDEN
Show
Dividend Yield
Lowest
Average
Highest
Buyback Yield
HIDDEN
Debt Paydown Yield
HIDDEN

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y
What is the Intrinsic Value of one Korea United Pharm Inc stock?

The intrinsic value of one Korea United Pharm Inc stock under the Base Case scenario is hidden KRW.

Is Korea United Pharm Inc stock undervalued or overvalued?

Compared to the current market price of 19 600 KRW, Korea United Pharm Inc is hidden .

Back to Top